Evidence map›Paper›PMID 33188175›Full record

ArticleNature communications2020

CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks.

Magdalena B Rother, Stefania Pellegrino, Rebecca Smith, Marco Gatti, Cornelia Meisenberg, Wouter W Wiegant, Martijn S Luijsterburg, Ralph Imhof, Jessica A Downs, Alfred C O Vertegaal and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 5 countries.

Magdalena B RotherDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Stefania PellegrinoDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
Rebecca SmithUniv Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes)-UMR 6290, BIOSIT-UMS3480, F-35000, Rennes, France.ORCID 0000-0002-1658-5635
Marco GattiDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
Cornelia MeisenbergThe Institute of Cancer Research, Royal Cancer Hospital, London, UK.
Wouter W WiegantDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Martijn S LuijsterburgDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Ralph ImhofDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
Jessica A DownsThe Institute of Cancer Research, Royal Cancer Hospital, London, UK.ORCID 0000-0002-6600-849X
Alfred C O VertegaalDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
Sébastien HuetUniv Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes)-UMR 6290, BIOSIT-UMS3480, F-35000, Rennes, France.ORCID 0000-0002-3978-0003
Matthias AltmeyerDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland. matthias.altmeyer@uzh.ch.ORCID 0000-0003-3780-1170
Haico van AttikumDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. h.van.attikum@lumc.nl.ORCID 0000-0001-8590-0240
Leiden University Medical Center · NLUniversity of Zurich · CHCentre National de la Recherche Scientifique · FRInstitute of Cancer Research · GB

Funding

Cancer Research UK 25715European Research Council 714326Medical Research Council MR/N02155X/1Medical Research Council MR/N02155X/2
6 · The paper itself

Abstract

Chromatin structure is dynamically reorganized at multiple levels in response to DNA double-strand breaks (DSBs). Yet, how the different steps of chromatin reorganization are coordinated in space and time to differentially regulate DNA repair pathways is insufficiently understood. Here, we identify the Chromodomain Helicase DNA Binding Protein 7 (CHD7), which is frequently mutated in CHARGE syndrome, as an integral component of the non-homologous end-joining (NHEJ) DSB repair pathway. Upon recruitment via PARP1-triggered chromatin remodeling, CHD7 stimulates further chromatin relaxation around DNA break sites and brings in HDAC1/2 for localized chromatin de-acetylation. This counteracts the CHD7-induced chromatin expansion, thereby ensuring temporally and spatially controlled 'chromatin breathing' upon DNA damage, which we demonstrate fosters efficient and accurate DSB repair by controlling Ku and LIG4/XRCC4 activities. Loss of CHD7-HDAC1/2-dependent cNHEJ reinforces 53BP1 assembly at the damaged chromatin and shifts DSB repair to mutagenic NHEJ, revealing a backup function of 53BP1 when cNHEJ fails.

Indexed as

DNA Breaks, Double-StrandedCell Line, TumorChromatinDNA-Binding ProteinsDNA End-Joining RepairDNA HelicasesDNA Ligase ATPGreen Fluorescent ProteinsHistone Deacetylase 1HumansKu AutoantigenPoly (ADP-Ribose) Polymerase-1Tumor Suppressor p53-Binding Protein 1Ubiquitin-Protein LigasesCHD7 protein, humanChromatinDNA-Binding ProteinsDNA HelicasesDNA Ligase ATPGreen Fluorescent ProteinsHDAC1 protein, humanHistone Deacetylase 1Ku AutoantigenLIG4 protein, humanPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1RNF168 protein, humanRNF8 protein, humanTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Ubiquitin-Protein Ligases

Identifiers

PMID33188175
PMCPMC7666215
OpenAlexW3101044899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.